Literature DB >> 24461885

Asthma heterogeneity and severity-why is comprehensive phenotyping important?

Wendy C Moore1, Eugene R Bleecker2.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 24461885      PMCID: PMC4029153          DOI: 10.1016/S2213-2600(13)70288-1

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  13 in total

1.  Dupilumab in persistent asthma.

Authors:  Sally E Wenzel; Lin Wang; Gianluca Pirozzi
Journal:  N Engl J Med       Date:  2013-09-26       Impact factor: 91.245

2.  Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma.

Authors:  William W Busse; Stephen Holgate; Edward Kerwin; Yun Chon; Jingyuan Feng; Joseph Lin; Shao-Lee Lin
Journal:  Am J Respir Crit Care Med       Date:  2013-12-01       Impact factor: 21.405

3.  Lebrikizumab treatment in adults with asthma.

Authors:  Jonathan Corren; Robert F Lemanske; Nicola A Hanania; Phillip E Korenblat; Merdad V Parsey; Joseph R Arron; Jeffrey M Harris; Heleen Scheerens; Lawren C Wu; Zheng Su; Sofia Mosesova; Mark D Eisner; Sean P Bohen; John G Matthews
Journal:  N Engl J Med       Date:  2011-08-03       Impact factor: 91.245

4.  Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis.

Authors:  Wendy C Moore; Annette T Hastie; Xingnan Li; Huashi Li; William W Busse; Nizar N Jarjour; Sally E Wenzel; Stephen P Peters; Deborah A Meyers; Eugene R Bleecker
Journal:  J Allergy Clin Immunol       Date:  2013-12-09       Impact factor: 10.793

Review 5.  Asthma and obesity.

Authors:  L-P Boulet
Journal:  Clin Exp Allergy       Date:  2013-01       Impact factor: 5.018

6.  Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial.

Authors:  P Nair; M Gaga; E Zervas; K Alagha; F E Hargreave; P M O'Byrne; P Stryszak; L Gann; J Sadeh; P Chanez
Journal:  Clin Exp Allergy       Date:  2012-07       Impact factor: 5.018

7.  Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.

Authors:  Ian D Pavord; Stephanie Korn; Peter Howarth; Eugene R Bleecker; Roland Buhl; Oliver N Keene; Hector Ortega; Pascal Chanez
Journal:  Lancet       Date:  2012-08-18       Impact factor: 79.321

8.  A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations.

Authors:  Klaus Bønnelykke; Patrick Sleiman; Kasper Nielsen; Eskil Kreiner-Møller; Josep M Mercader; Danielle Belgrave; Herman T den Dekker; Anders Husby; Astrid Sevelsted; Grissel Faura-Tellez; Li Juel Mortensen; Lavinia Paternoster; Richard Flaaten; Anne Mølgaard; David E Smart; Philip F Thomsen; Morten A Rasmussen; Silvia Bonàs-Guarch; Claus Holst; Ellen A Nohr; Rachita Yadav; Michael E March; Thomas Blicher; Peter M Lackie; Vincent W V Jaddoe; Angela Simpson; John W Holloway; Liesbeth Duijts; Adnan Custovic; Donna E Davies; David Torrents; Ramneek Gupta; Mads V Hollegaard; David M Hougaard; Hakon Hakonarson; Hans Bisgaard
Journal:  Nat Genet       Date:  2013-11-17       Impact factor: 38.330

9.  Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation.

Authors:  Florence N Schleich; Maité Manise; Jocelyne Sele; Monique Henket; Laurence Seidel; Renaud Louis
Journal:  BMC Pulm Med       Date:  2013-02-26       Impact factor: 3.317

10.  Quantitative computed tomography-derived clusters: redefining airway remodeling in asthmatic patients.

Authors:  Sumit Gupta; Ruth Hartley; Umair T Khan; Amisha Singapuri; Beverly Hargadon; William Monteiro; Ian D Pavord; Ana R Sousa; Richard P Marshall; Deepak Subramanian; David Parr; James J Entwisle; Salman Siddiqui; Vimal Raj; Christopher E Brightling
Journal:  J Allergy Clin Immunol       Date:  2013-11-12       Impact factor: 10.793

View more
  7 in total

1.  Epigenome-wide analysis links SMAD3 methylation at birth to asthma in children of asthmatic mothers.

Authors:  Avery DeVries; Gabriela Wlasiuk; Susan J Miller; Anthony Bosco; Debra A Stern; I Carla Lohman; Janet Rothers; Anya C Jones; Jessie Nicodemus-Johnson; Monica M Vasquez; John A Curtin; Angela Simpson; Adnan Custovic; Daniel J Jackson; James E Gern; Robert F Lemanske; Stefano Guerra; Anne L Wright; Carole Ober; Marilyn Halonen; Donata Vercelli
Journal:  J Allergy Clin Immunol       Date:  2016-12-21       Impact factor: 10.793

2.  ADAMTS7 Attenuates House Dust Mite-Induced Airway Inflammation and Th2 Immune Responses.

Authors:  Anil Kumar Jaiswal; Amarjit Mishra
Journal:  Lung       Date:  2022-05-03       Impact factor: 3.777

3.  Short palate, lung, and nasal epithelial clone 1 (SPLUNC1) level determines steroid-resistant airway inflammation in aging.

Authors:  Anil Kumar Jaiswal; Jyoti Yadav; Sangeet Makhija; Maninder Sandey; Amol Suryawanshi; Amit Kumar Mitra; Amarjit Mishra
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-12-01       Impact factor: 5.464

4.  Irg1/itaconate metabolic pathway is a crucial determinant of dendritic cells immune-priming function and contributes to resolute allergen-induced airway inflammation.

Authors:  Anil Kumar Jaiswal; Amarjit Mishra; Jyoti Yadav; Sangeet Makhija; Suman Mazumder; Amit Kumar Mitra; Amol Suryawanshi; Maninder Sandey
Journal:  Mucosal Immunol       Date:  2021-10-20       Impact factor: 7.313

Review 5.  Asthma and Allergy: Unravelling a Tangled Relationship with a Focus on New Biomarkers and Treatment.

Authors:  Pablo Rodriguez Del Rio; Andrew H Liu; Magnus P Borres; Eva Södergren; Fabio Iachetti; Thomas B Casale
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

6.  Intraepithelial neutrophils in pediatric severe asthma are associated with better lung function.

Authors:  Cecilia K Andersson; Alexandra Adams; Prasad Nagakumar; Cara Bossley; Atul Gupta; Daphne De Vries; Afiqah Adnan; Andrew Bush; Sejal Saglani; Clare M Lloyd
Journal:  J Allergy Clin Immunol       Date:  2016-10-13       Impact factor: 10.793

7.  Overlap of allergic, eosinophilic and type 2 inflammatory subtypes in moderate-to-severe asthma.

Authors:  Meng Chen; Kirk Shepard; Ming Yang; Pranil Raut; Hooman Pazwash; Cecile T J Holweg; Eugene Choo
Journal:  Clin Exp Allergy       Date:  2021-01-07       Impact factor: 5.018

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.